Condition
CD - Crohn's Disease
Total Trials
5
Recruiting
2
Active
2
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (3)
Trial Status
Recruiting2
Completed2
Not Yet Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT07444060RecruitingPrimary
Guselkumab Vs Ustekinumab in Stricturing Crohn's Disease
NCT07409376Not ApplicableNot Yet RecruitingPrimary
Comparison of the Therapeutic Effects of Balloon Assisted Enteroscopy Assisted Narrow Incision and Balloon Dilation in the Treatment of Crohn's Disease Small Intestinal Stenosis
NCT07385131Recruiting
Prophylactic Dexamethasone Before Infliximab in Moderate-to-Severe IBD
NCT03872622Not ApplicableCompletedPrimary
Intestinal Response Patterns to Microbial Signals
NCT03555058Not ApplicableCompletedPrimary
The CURE - CD Trial
Showing all 5 trials